Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2, indicating a small site update. No study information or content is affected.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study page now includes an explicit note that recruitment is closed to participants, clarifying current enrollment status. In addition, header formatting for Intervention/Treatment is reformatted and new help/navigation items such as How to Read a Study Record, Common Questions, How to Join a Study, and a Revision note (v3.6.0) were added.SummaryDifference0.4%

- Check25 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, signaling a metadata update to the ClinicalTrials.gov entry.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 to reflect a newer site build.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page’s footer revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor site/version update without changing the study details.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.